Statistics

Total Visits

Views
A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results53

Select a period of time:

Number of views in the range

Views
A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results26

Views

Views
December 20241
January 20252
February 20253
March 202512
April 20254
May 20252
June 20252
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States12
Singapore11
Brazil1
Spain1
United Kingdom1
 

Top cities views

Views
Belo Horizonte1
Buffalo1
Council Bluffs1
Redhill1